[焦点细分质硬化症的诊断和治疗-2023]
Philipp Gauckler1, Emanuel Zitt2, Heinz Regele3
1Department Innere Medizin IV (Nephrologie und Hypertensiologie), Medizinische Universität Innsbruck, Innsbruck, Österreich. philipp.gauckler@i-med.ac.at.
Wiener klinische Wochenschrift
|September 20, 2023
概括
焦点细分质硬化症 (FSGS) 涉及各种原因,其特点是高蛋白尿和特定的病变. 这一共识为诊断和管理FSGS提供了指导,区分其子类型以进行适当的治疗.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病理学 病理学 病理学
- 免疫学 免疫学 免疫学
背景情况:
- 焦点细分性淋巴结核硬化 (FSGS) 是一种由特定病变和高蛋白尿症定义的病.
- 了解潜在的原因 (原发性,二次性,遗传性) 对于有效的管理至关重要.
- 主要FSGS的发病因子尚不清楚,但可能涉及自身免疫 podocyte 损伤,将其与最小变化疾病联系起来,称为"podocytopathy".
研究的目的:
- 为诊断和管理焦点细分质硬化症 (FSGS) 提供共识性建议.
- 区分FSGS的初级,二级和遗传形式.
- 根据FSGS亚型指导治疗策略,包括支持性护理和免疫抑制.
主要方法:
- 由奥地利脏病学会 (ÖGN) 开发的共识.
- 审查目前对FSGS病原和临床表现的理解.
- 制定不同FSGS亚型的诊断和管理指南.
主要成果:
- 支持性治疗对于所有FSGS亚型来说至关重要,以保持功能.
- 免疫抑制疗法特别适用于初级FSGS.
- 管理FSGS的挑战包括类固醇依赖,耐药性和频繁复发,需要采用替代策略.
结论:
- 准确的诊断和亚型差异化对于最佳的FSGS患者护理至关重要.
- 量身定制的治疗方法,考虑支持性和免疫抑制疗法,是管理FSGS的关键.
- 该ÖGN的建议旨在改善焦点细分质硬化症患者的治疗结果.
相关概念视频
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:28Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
01:24Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
01:24Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
01:27Open Angle Glaucoma: Treatment
477
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
477